NO154132B - Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e tiazolinderivater. - Google Patents

Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e tiazolinderivater. Download PDF

Info

Publication number
NO154132B
NO154132B NO801995A NO801995A NO154132B NO 154132 B NO154132 B NO 154132B NO 801995 A NO801995 A NO 801995A NO 801995 A NO801995 A NO 801995A NO 154132 B NO154132 B NO 154132B
Authority
NO
Norway
Prior art keywords
methyl
chloro
thiazoline
melting point
imino
Prior art date
Application number
NO801995A
Other languages
English (en)
Norwegian (no)
Other versions
NO801995L (no
Inventor
Hans-Joechen Lang
Bernhard Seuring
Ernold Granzer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO801995L publication Critical patent/NO801995L/no
Publication of NO154132B publication Critical patent/NO154132B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/66Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to halogen atoms or to nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/36Isothioureas having sulfur atoms of isothiourea groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO801995A 1979-07-03 1980-07-02 Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e tiazolinderivater. NO154132B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792926771 DE2926771A1 (de) 1979-07-03 1979-07-03 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO801995L NO801995L (no) 1981-01-05
NO154132B true NO154132B (no) 1986-04-14

Family

ID=6074772

Family Applications (2)

Application Number Title Priority Date Filing Date
NO801995A NO154132B (no) 1979-07-03 1980-07-02 Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e tiazolinderivater.
NO844120A NO844120L (no) 1979-07-03 1984-10-16 Tiazolinderivater og fremgangsmaate for dets fremstilling

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO844120A NO844120L (no) 1979-07-03 1984-10-16 Tiazolinderivater og fremgangsmaate for dets fremstilling

Country Status (16)

Country Link
US (1) US4346088A (es)
EP (1) EP0023964B1 (es)
JP (1) JPS5610180A (es)
AR (3) AR229875A1 (es)
AT (1) ATE2524T1 (es)
AU (1) AU533589B2 (es)
CA (1) CA1156240A (es)
DE (2) DE2926771A1 (es)
DK (1) DK286580A (es)
EG (1) EG14763A (es)
ES (5) ES492847A0 (es)
FI (1) FI802094A (es)
HU (1) HU182164B (es)
IL (1) IL60468A (es)
NO (2) NO154132B (es)
ZA (1) ZA803979B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049460A1 (de) * 1980-12-30 1982-07-29 Hoechst Ag, 6000 Frankfurt "thiazolinderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
CA2195847A1 (en) * 1994-07-27 1996-02-08 John J. Talley Substituted thiazoles for the treatment of inflammation
IL144031A0 (en) * 1999-01-14 2002-04-21 Bayer Ag Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
US6353006B1 (en) 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
FR2796643B1 (fr) * 1999-07-22 2005-04-29 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
ATE393150T1 (de) * 1999-09-14 2008-05-15 Shionogi & Co 2-imino-1,3-thiazin-derivate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
SE7700436L (sv) * 1976-01-17 1977-07-18 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning

Also Published As

Publication number Publication date
ZA803979B (en) 1981-06-24
ES492872A0 (es) 1981-02-16
CA1156240A (en) 1983-11-01
EG14763A (en) 1986-09-30
ATE2524T1 (de) 1983-03-15
IL60468A (en) 1984-11-30
DE3062017D1 (en) 1983-03-24
DK286580A (da) 1981-01-04
ES8103068A1 (es) 1981-02-16
AR229875A1 (es) 1983-12-30
ES492874A0 (es) 1981-02-16
AR226119A1 (es) 1982-05-31
ES492873A0 (es) 1981-02-16
DE2926771A1 (de) 1981-01-15
EP0023964A1 (de) 1981-02-18
NO844120L (no) 1981-01-05
JPS5610180A (en) 1981-02-02
FI802094A (fi) 1981-01-04
AU533589B2 (en) 1983-12-01
AU6003780A (en) 1981-01-15
ES492871A0 (es) 1981-02-16
US4346088A (en) 1982-08-24
EP0023964B1 (de) 1983-02-16
ES8103066A1 (es) 1981-02-16
ES8103065A1 (es) 1981-02-16
ES8103069A1 (es) 1981-02-16
IL60468A0 (en) 1980-09-16
ES492847A0 (es) 1981-02-16
NO801995L (no) 1981-01-05
HU182164B (en) 1983-12-28
ES8103067A1 (es) 1981-02-16
AR229876A1 (es) 1983-12-30

Similar Documents

Publication Publication Date Title
US4287200A (en) Thiazolidine derivatives
SU1099843A3 (ru) Способ получени производных 5-замещенного оксазолидин-2,4-диона или их фармацевтически приемлемых солей
NO812558L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksazolidin-derivater.
NO157896B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme tiazolidindion-derivater.
CA2669069A1 (en) Process for the preparation of 2-imino-thiazolidin-4-one derivatives
KR101701531B1 (ko) 벤조티아진 유도체, 이의 제조방법 및 약물로서의 용도
IE920734A1 (en) 4-aryl-thiazole or imidazole derivatives
NO154132B (no) Analogifremgangsm¨te til fremstilling av terapeutisk aktiv e tiazolinderivater.
AU599014B2 (en) 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
EP0398179B1 (en) Rhodanine derivatives and pharmaceutical compositions
US4421757A (en) Thiazoline derivatives, processes for their preparation, their use and pharmaceutical preparations based on these compounds
Miller et al. By-products of the Willgerodt Reaction Applied to α-and γ-Picoline
Tarbell et al. 2-Methyl-5-ethoxythiazole and Related Compounds1
US2858318A (en) p-substituted benzene sulphonamides
CZ304804B6 (cs) Způsob přípravy derivátu thiazolu
HU198915B (en) Process for producing new 2-thiazolidinone derivatives and pharmaceutical compositions containing them
US4118501A (en) Thiazolidine derivatives
KR850000757B1 (ko) 티아졸린 유도체의 제조방법
JP3190959B2 (ja) 4−メチル−5−(2−クロロエチル)−チアゾールおよびその同族体の新規な製法
US4156735A (en) Thiazolidine derivatives
NO131345B (es)
US4002620A (en) 2-Anilino-4H-3,1-benzothiazines
RU2103264C1 (ru) Способ получения производных тиазола или их солей присоединения кислот, 5-хлор-3-тиоцианато-2-алканон и способ его получения
DD223450A5 (de) Verfahren zur herstellung von benzofuranonen
IE922238A1 (en) Process for the preparation of the dextrorotatory isomer of an isoindolinone derivative